I don’t know why I’m even bothering with a post that isn’t about Apple, when the entire globe — perhaps even the universe — is holding its breath waiting for news, but I have to say that the Facebook-buying-Plaxo rumour makes sense to me. I know that both Eric Eldon at VentureBeat and Mike Arrington at TechCrunch make a good case for why it might not happen, but I think it could.
Eric notes — as does Valleywag — that there is reportedly some bad blood between Facebook-backer Peter Thiel and Plaxo-backer Michael Moritz over some previous Silicon Valley deall, and Mike says that the numbers behind Plaxo aren’t that attractive for Facebook, especially at the $200-million valuation the site is looking for.
That may all be true, but I tend to agree with Henry Blodget on this one: adding the features of Plaxo, which allows users to import contact data from all kinds of different services, would make a lot of sense for Facebook, and even at $200-million it would be cheap given the (theoretical) $15-billion valuation Facebook has. Why not do it? I can’t see a tiff between Thiel and Moritz holding back an idea if it makes sense.